Discover why Altimmune (ALT) and Viking Therapeutics (VKTX) are top picks for high-risk investors. Click here to read my most ...

Four months after Vertex Pharmaceuticals Inc.’s U.S. FDA nod for Journavx (suzetrigine) as the first drug targeting NaV1.8 for treating pain, Eli Lilly and Co. is joining the potential competition via ...

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. On May 27, 2025, the voluntary ...

Alkermes has agreed a $950 million deal to acquire Rodin Therapeutics ... That left a hole in Alkermes' pipeline and made it even more reliant on schizophrenia and bipolar candidate ALKS 3831 ...

The Alzheimer's agreement – with Denmark's Muna Therapeutics – will see the ... Rgenta's in-house pipeline is headed by RGT-61159, a drug designed to inhibit the production of the cancer ...